Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) EPS (Weighted Average and Diluted): 2022-2024

Historic EPS (Weighted Average and Diluted) for Soleno Therapeutics (SLNO) over the last 3 years, with Dec 2024 value amounting to -$4.38.

  • Soleno Therapeutics' EPS (Weighted Average and Diluted) rose 86.88% to -$0.21 in Q2 2016 from the same period last year, while for Jun 2016 it was -$0.75, marking a year-over-year increase of 51.26%. This contributed to the annual value of -$4.38 for FY2024, which is 85.59% down from last year.
  • As of FY2024, Soleno Therapeutics' EPS (Weighted Average and Diluted) stood at -$4.38, which was down 85.59% from -$2.36 recorded in FY2023.
  • Soleno Therapeutics' 5-year EPS (Weighted Average and Diluted) high stood at -$2.36 for FY2023, and its period low was -$4.38 during FY2024.
  • Its 3-year average for EPS (Weighted Average and Diluted) is -$3.20, with a median of -$2.87 in 2022.
  • In the last 5 years, Soleno Therapeutics' EPS (Weighted Average and Diluted) climbed by 17.77% in 2023 and then tumbled by 85.59% in 2024.
  • Over the past 3 years, Soleno Therapeutics' EPS (Weighted Average and Diluted) (Yearly) stood at -$2.87 in 2022, then rose by 17.77% to -$2.36 in 2023, then slumped by 85.59% to -$4.38 in 2024.